Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2025-12-31 @ 5:50 AM
Study NCT ID:
NCT01192633
Status:
UNKNOWN
Last Update Posted:
2010-09-01
First Post:
2010-03-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With Sarcoma
Sponsor:
Fudan University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GVP-SAR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Base for drug clinical trials, Fudan University cancer hospital
Old Organization:
Fudan University cancer hospital